Abdul Wase, MBBS

Professor, Internal Medicine; Program Director, Cardiovacular Disease
Premier Cardiovascular, 6251 Miami Valley Way Ste 220, Dayton, OH 45424

Clinical Faculty:

Assistant/Associate Clinical Professor of Medicine                                                                                                                         1994-2018

Professor of Medicine                                                                                                                                                                       2018- Current

Administrative Appointment:

Program Director, Cardiology Fellowship, Wright State University Boonshoft School of Medicine                                                     1999-2006

Program Director, Cardiology Fellowship, Wright State University Boonshoft School of Medicine                                                     2011-2018

Journal Reviewer:

Journal of American College of Cardiology (JACC)

American Journal of Cardiology (AJC)

American Journal of Kidney Diseases (AJKD)

Journal of Atrial Fibrillation (JAFIB)


Recipient of “Lifetime Achievement Award” given by the World Congress of Clinical and Preventive Cardiology, 2006 at Rashtrapati Bhawan, New Delhi, India, conferred upon by His Excellency A.P.J. Abdul Kalam, President, Republic of India

Doctor of Science (honoris causa), University of Science and Technology, Meghalaya, India Dec 2021

Education History


MBBS , Jawaharlal Nehru Medical College, Aligarh Muslim University, Aligarh, India


Cook County Hospital, Chicago, Illinois

Fellowship in Cardiology:

Cook County Hospital, Chicago, Illinois

Fellowship in Cardiac Electrophysiology

Sinai Samaritan Hospital, University of Milwaukee, Wisconsin


Current Position:

Staff Electrophysiologist, Premier Cardiovascular Institute, Miami Valley Hospital, Dayton, OH

Professor, Wright State University Boonshoft School of Medicine, Dayton, OH                                     

Research Statement


  1. Aung TT, Roberto ES, Wase A: Absent Left Main Coronary Artery and Separate Ostia of Left Coronary System in a Patient with Holt-Oram Syndrome and Sinus Node Dysfunction Am J Case Rep. 2016 Feb 17;17:93-6.
  2. Mufti OI, Quraishi MB, Kabir MA, Markert R and Wase A: Propofol Administration by Electrophysiologist Versus an Anesthesiologist During Cardiac ResynchronizationTherapy-Defibrillator (CRT-D) Implantation: Is an Anesthesiologist Necessary? (Int J. Cardiovasc Res 2014, 3:4)
  3. Wase A, Masood AM, Garikipati NV, Mufti O, Kabir A: Bidirectional ventricular tachycardia with myocardial infarction: A case report with insight on mechanism and treatment. Indian Heart J. 2014 66 (4):466-9
  4. Jabbar AA. Wase A: Worsening Wenckebach after calcium gluconate injection: not uncommon but frequently missed diagnosis: Am J Emerg Med 2013;31 (5):893
  5. Ali O, Wase A. Anomalous venous circuit: a detour to the heart BMJ Case Rep. 2012;
  6. Wase A, Garikipati N, Mufti O, Mirza Z, Innaparthy A, Kabir A, Quraishi MB, Markert R. Effect of spironolactone on ventricular arrhythmias in patients with left ventricular systolic dysfunction and implantable cardioverter defibrillators Indian Heart J. 2012 64 (2):123-7
  7. Wase, A:  Elevated defibrillation thresholds with biventricular pacing. Heart Rhythm. 2007 Feb;4(2):253
  8. Ahmed N,  Riaz K, Rai R, Khalid A, Wase A: Levofloxacin-Induced Torsade des Pointes. Resident and Staff Physician. 2007; 53 (1) A Case Report with insights into Mechanisms.
  9. Ahmed N,  Riaz K, Rai R, Osman M, Wase A. Congenital Long QT Syndrome. Rev Cardiovasc Med. 2006 Summer; 7 (3): 160-5 A Case Report with Review of Literature
  10. Wase A. Antiarrhythmic Therapy for Prevention of Implantable Cardioverter Defibrillator Shocks. JAMA.2006; 296: 1229 A Letter to the Editor
  11. McCullough PA, Wase A: Do implantable cardioverter-defibrillators improve survival in dialysis patients after cardiac arrest? Nat Clin Pract Nephrol. 2006 Feb;2(2):70-1. Practice Point Commentary
  12. Wase A, Wilson A: Wearable Defibrillators: A New Tool in the Management of Ventricular Tachyardia/Ventricular Fibrillation. EP Lab Digest 2005 Dec 5 (12)
  13. Wase A: Arrhythmia and Chronic Kidney Disease- A Triple Jeopardy: Journal of Geriatric Cardiology 2005 ;2 (3): 178-83
  14. Wase A, Shah S, Siraj Y, Nazir R: AV Nodal Reentrant Tachycardia with Advanced AV Block: Journal of Interventional Cardiac Electrophysiology 2005 Apr;12(3):227-30 Case Report
  15. Wase A, Basit A, Nazir R et al: Impact of Chronic Kidney Disease on Survival among ICD recipients: Journal of Interventional Cardiac Electrophysiology; 2004: 11,199-204
  16. Wase A: Random Component Failure of an ICD: Journal of Interventional Cardiac Electrophysiology; 10,175-176, 2004 A Case Report
  17. Mehdirad A A, Fatkin D, DiMarco J P, MacRae C A, Wase A, Seidman JG, Seidman C E, Benson D W, Electrophysiology Characteristics of Accessory Atrioventricular Connections in an Inherited Form of Wolff-Parkinson-White Syndrome. Journal of Cardiovascular Electrophysiology, Volume 10, No. 5, pp. 629-635, May 1999
  18. Wase A, Natale A, Dhala A, Deshpande S, Sra J, Blanck Z, Maglio C, Jazayeri M, Akhtar M, Sensing failure in a tiered therapy implantable cardioverter defibrillator: Role of auto adjustable gain. PACE 1995; 18:1327-1330
  19. Natale A, Sra J, Axtell K, Maglio C, Dhala A, Deshpande S, Jazayeri M, Wase A, Akhtar M. Preliminary Experience with a hybrid nonthoracotomy defibrillating system including a biphasic device: Comparison with a standard monophasic device using the same lead system. J. Amer. Coll. Cardiol. 1994: 24: 406-12
  20. Natale A, Sra J, Dhala A, Wase A, Jazayeri M, Deshpande S, Blanck Z, and Akhtar M. Efficacy of Different Treatment Strategies for Neurocardiogenic Syncope PACE: 1995; 18:655-662.
  21. Natale A, Sra J, Krum D, Dhala A, Deshpande, S, Jazayeri M, Newby K, Wase A, Axtell K, VanHout W, Akhtar M. Relative Efficacy of Different Tilts with Biphasic Defibrillation in Humans. PACE: 1996 19:197-206.
  22. Natale A, Kearney M, Brandon M., Kent V, Wase A, Newby K, Pisano E, Geiger M. Safety of Nurse-Administered Deep Sedation for Defibrillator Implantation in the Electrophysiology Laboratory. Journal of Cardiovascular Electrophysiology.  Vol.7, No.4, April 1996
  23. Geiger MJ, Wase A, Kearney M, Brandon M.J, Kent V, Newby KH, Natale A: Evaluation of the Safety and Efficacy of Deep Sedation for Electrophysiology Procedures Administered in the Absence of an Anesthetist.  PACE Vol 20, No. 7, July 1997




  1. Wase A, Quraishi B, Kabir A, Mufti O, Sacksteder S, Shafer H, Mahaffe J, Hoersten C, Markert R: Can Propofol Be Administered Safely by an Electrophysiologist versus an Anesthesiologist during Biventricular Cardioverter-Defibrillator Implantation. Presented at the American College of Cardiology 60th Annual Scientific Session in April 2-5, 2011, in New Orleans, Louisiana
  2. Wase A, Mirza Z, Innaparthy A, Kabir A, Quraishi MB, Markert M: Spironolactone Suppresses the Frequency of Ventricular Arrhythmias among Patients with Left Ventricular Systolic Dysfunction and Implantable Cardioverter-Defibrillators. Presented at Heart Failure Society of America 12th Annual Scientific Session, on September 14, 2010, San Diego, CA
  3. Wase A, Quraishi B, Kabir A, Mufti O, Sacksteder S, Shafer H, Mahaffe J, Hoersten C,     Markert R: Creatinine and Defibrillation Threshold among Patients with Congestive Heart Failure with a Biventricular ICD:Is There a Correlation? Presented at Heart Failure Society of America 12th Annual Scientific Session, on September 14, 2010, San Diego, CA
  4. Wase A, Basit A, Khan T, McCullough  PA: Is Chronic Kidney Disease Associated with Poor Survival Among Implantable Cardioverter Defibrillator Recipients? Heart Rhythm Journal (Supplement) May, 2004
  5. Wase, A, Basit, A, Hill, T, Nazir, R, Does Chronic Renal Insufficiency Raise Defibrillation Thresholds? PACE 25: 4, Part II, 594, 2002 (REFERENCE CITED IN BRAUNWAULD 7th EDITION )
  6. Dhala A, Deshpande S, Blanck Z, Wase A, Sheth M.Jazayeri, Sra J, Avitall B, Akhtar M, Is "nonclinical" induced ventricular tachycardia a clinical problem? JACC 21:II 328A, 1993
  7. Natale A, Sra J, Avitall B, Dhala A, Deshpande S,  Jazayeri MR, Wase A, Sheth M, Akhtar M. Specificity of head-up tilt: Effect of degree of tilt and isoproterenol infusion. JACC 21;2:157A, Feb 1993
  8. Natale A, Sra J, Avitall B, Dhala A, Deshpande S, Jazayeri MR, Axtell K, Wase A, Sheth M, Akhta M: Stability of defibrillation threshold greater than 20 joules with nonthoracotomy lead system. JACC 21;2:170A. Feb. 1993
  9. Dhala A, Deshpande S, Blanck Z, Wase A, Sheth M, Jazayeri M, Sra J, Avitall B, Akhtar M, Electrophysiologic significance of new Q waves in right precordial ECG leads following right bundle ablation. JACC 21:244A, 1993
  10. Natale A, Jazayeri M, Dhala A, Deshpande S, Wase A, Krebs A, Akhtar M,  Sra J.  Provocation of hypotension during head-up tilt testing in subjects with no history of syncope or presyncope.  Circulation 1995; 92:54-58
  11. Natale A, Sra J, Avitall b, Maglio C, Deshpande S, Axtell K, Wase A, Sheth M, Akhtar M, Does placement of a defibrillation catheter in the coronary sinus affect patency of the vessel and long-term stability of the lead system? Circulation 88:I-155 1993
  12. Natale A, Sra J, Dhala A, Wase A, Maglio C, Krebs A, Chudnohufsky S, Akhtar M. Clinical follow-up in 327 patients with positive head-up tilt: How should appropriate therapy be chosen. Circulation 88:4; Oct 1993 (Supplement)
  13. Sra J, Natale A, Wase A, Maglio C, Bremner S, Jazayeri MR.  Atrial premature stimulation via radiofrequency catheter: A guide to identify site of slow pathway ablation. Circulation 88:4; Oct 1993 (Supplement)
  14. Blanck Z, Dhala A, Krum D, Wase A, Avitall B, Sheth M, Deshpande S, Akhtar M, Jazayeri MR, Dramatic reduction in ventricular response during atrial fibrillation by ablating the atrioventricular nodal slow pathway: Electrophysiologic and clinical implications. Circulation 88:I-584, 1993
  15. Biehl M, Sheth M, Wase A, Deshpande S, Moghaddam M, Dhala A, Banks B, Sra J, Broihier T, Akhtar M, Jazayeri, M.  A new proposal for classification of uncommon atrioventricular nodal reentrant tachycardia. JACC 249A 1994
  16. Jazayeri M, Moghaddam M, Deshpande S, Wase A, Biehl M, Banks B, Natale A, Dhala A, Sra J, Akhtar M: Penetration of AVN reentrant circuit during atrial extrastimulation without resetting tachycardia cycle length: Further insights into the anatomic boundary of reentry.  JACC 376A, 1994
  17. Natale A, Sra J, Avitall B, Wase A, Axtell K, Dhala A, Deshpande S, Jazayeri M, Maglio C, Akhtar M, Ventricular tachycardia: Is bypass surgery enough? JACC 421A, 1994
  18. A, Sra J, Deshpande S, Dhala A, Wase A, Maglio C, Budziszewski M, Axtell K, Akhtar M. Effects of the initial polarity of biphasic pulses on Defibrillation efficacy. Circulation: Oct 1994 (Supplement)
  19. Krum D, Shetty S, Hare J, Silverstein S, Ishii TK, Khan, M, Biehl M, Wase A, Akhtar M, Jazayeri M. Characteristics of Myocardial lesions created using Microwave Energy: Optimization of Antenna Design. Circulation: Oct 1994 (Supplement)
  20. Natale A, Sra J, Jazayeri M, Blanck Z, Wase A, Bremmer S, Koch K, Akhtar M. Clinical Significance of AV Nodal Block During Radiofrequency Modification with the Posterior Approach. Circulation: Oct 1994 (Supplement)
  21. Natale, Andrea; Sra, Jasbir; Dhala, Anwer; Biehl, Michael; Wase, Abdul; Deshpande, Sanjay; Maglio, Cheryl; Budziszewski, Margaret; Akhtar, Masood Does Vasodepressor Syncope Require Normal Ventricular Function JACC Vol. 25, Issue: 2, February, 1995. pp. 92A
Is this you? Log in to update your profile.